Abstract:Tumor is one of the most serious threats for human being. Although many anti-tumor drugs are approved for clinical use, the treatment outcome is still modest because of the poor tumor targeting efficiency and low accumulation in tumor. Therefore, it is important to deliver anti-tumor drug into tumor efficiently, elevate drug concentration in tumor tissues and reduce the drug distribution in normal tissues. And it has been one of the most attractive directions of pharmaceutical academy and industry. Many kinds of strategies, especially various nanoparticulated drug delivery systems, have been developed to address the critical points of complex tumor microenvironment, which are partially or mostly satisfied for tumor treatment. In this paper, we carefully reviewed the novel targeting delivery strategies developed in recent years. The most powerful method is passive targeting delivery based on the enhanced permeability and retention(EPR) effect, and most commercial nanomedicines are based on the EPR effect. However, the high permeability and retention require different particle sizes, thus several kinds of size-changeable nanoparticles are developed, such as size reducible particles and assemble particles, to satisfy the controversial requirement for particle size and enhance both tumor retention and penetration. Surface charge reversible nanoparticles also shows a high efficiency because the anionic charge in blood circulation and normal organs decrease the unintended internalization. The charge can change into positive in tumor microenvironment, facilitating drug uptake by tumor cells. Additionally, tumor microenvironment responsive drug release is important to decrease drug side effect, and many strategies are developed, such as p H sensitive release and enzyme sensitive release. Except the responsive nanoparticles, shaping tumor microenvironment could attenuate the barriers in drug delivery, for example, decreasing tumor collagen intensity and normalizing tumor microvessels to decrease the internal fluid pressure. All these strategies could enhance the accumulation and penetration of nanoparticles into tumor, leading to a homogenous distribution of drugs in tumor. To enhance the internalization by specific cells, active targeting delivery strategies are developed. There were many surface markers, receptors or carriers overexpressed on specific kinds of cells, thus the corresponding ligands were utilized to mediate active targeting to certain cells, including tumor cells, cancer stem cells, tumor neovasculatures, tumor associated macrophages and other tumor stroma cells. Targeting more than one cell type may provide an improved antitumor effect. Although these passive and active targeting strategies all have promising outcome in the treatment of tumor, some shortages are still unaddressed, such as the specificity of responsive is not good enough, and the active targeting may be diminished by the protein corona. Thus more research is required to promote the drug delivery study.

Research progress of tumor targeting drug delivery technology based on mediation of CD44

Advancement in Transporter-Oriented Nanoplatforms for Cancer Therapy

Different Targeting Ligands-Mediated Drug Delivery Systems for Tumor Therapy

Research Progress on Tumor-Targeting Immunoconjugate

“Smart” Nanocarriers: A New Paradigm for Tumor Targeting Drug Delivery Systems

Advances in Targeting Drug Biological Carriers for Enhancing Tumor Therapy Efficacy

Tumor-Targeted Drug Delivery With Aptamers

CD44 Glycosylation as a Therapeutic Target in Oncology

Advances in Glycosylation-Mediated Cancer-Targeted Drug Delivery.

[The Development of Novel Tumor Targeting Delivery Strategy].

Peptide-Mediated Nano Drug Delivery System for Tumor Targeting

A Review on Drug Delivery System for Tumor Therapy

The Targeted-liposome Delivery System of Antitumor Drugs

Recent Advances in Targeted Drug Delivery Strategy for Enhancing Oncotherapy

Targeted Drug Delivery in Pancreatic Cancer

The biology and role of CD44 in cancer progression: therapeutic implications

Liposomes for Tumor Targeted Therapy: A Review

Recent Advances and Strategies in Tumor Vasculature Targeted Nano-Drug Delivery Systems

"Targeting Design" of Nanoparticles in Tumor Therapy

Aptamers as Smart Ligands for Targeted Drug Delivery in Cancer Therapy

Advanced and Innovative Nano-Systems for Anticancer Targeted Drug Delivery